In the same cohorts, we analyzed herd immunity to HBV, both vaccine-induced, confirmed by the presence of antibodies to HBsAg (anti-HBs) only, and post-infection, indicated by reactivity for both anti-HBs and antibodies to HBV core antigen (anti-HBc), or for only anti-HBc. Here, KRT88P is linked to infection.